Hong Kong-listed Innovent Biologics Inc. is considering a licensing partnership to develop a cancer drug that’s showing ...

Promising therapies for platinum-resistant ovarian cancer produced mixed results in separate trials. The AKT inhibitor ...

Kerri Robbins, center, is pictured with her cousins Kim and Viki, with whom she has recently connected. Robbins found her ...

No one likes getting a colonoscopy. The procedure, used to check for colon cancer, is uncomfortable, expensive, and sometimes ...

As genetic and biomarker tests become more common, so do new therapies that target specific tumor types and may lead to ...

Biological age, rather than chronological age, may be a stronger predictor of colorectal cancer risk—especially in older ...

Zai Lab Announces Acceptance of Biologics License Application for TIVDAK for the Treatment of Patients with Recurrent or Metastatic Cervical Cancer Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688 ...

BURLINGAME, CA, UNITED STATES, March 10, 2025 /EINPresswire / -- Latest Report, titled“Cancer Biologics Market” Trends, Share, Size, Growth, Opportunity and Forecast 2025-2032, by Coherent ...

Turnstone Biologics (NASDAQ:TSBX – Get Free Report) is anticipated to post its quarterly earnings results before the market opens on Thursday, March 20th. Analysts expect Turnstone Biologics to post ...

PR+ breast cancer responds well to hormone therapy, underscoring the need for molecular insight and targeted treatment ...